Daniel Morvan
Institut National de la Santé et de la Recherche Médicale and Centre Jean Perrin
484 rue Montalembert
F-63005 Clermont-Ferrand
France
Name/email consistency: high
- Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Morvan, D., Demidem, A. Cancer Res. (2007)
- Methionine-dependence phenotype of tumors: metabolite profiling in a melanoma model using L-[methyl-13C]methionine and high-resolution magic angle spinning 1H-13C nuclear magnetic resonance spectroscopy. Morvan, D., Demidem, A., Guenin, S., Madelmont, J.C. Magn. Reson. Med (2006)
- Response of melanoma tumor phospholipid metabolism to chloroethyle nitrosourea: a high resolution proton NMR spectroscopy study. Morvan, D., Demidem, A., Madelmont, J.C. Pathol. Biol. (2003)
- Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Morvan, D., Demidem, A., Papon, J., De Latour, M., Madelmont, J.C. Cancer Res. (2002)
- Experimental evaluation of nonlinearities of small-sized insertable gradient coils. Morvan, D., Richard, B., Fredy, D. Magn. Reson. Imaging (1998)